TNhYP218 CAR T cells
/ National Cancer Institute
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 20, 2025
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: National Cancer Institute (NCI) | Not yet recruiting ➔ Recruiting
Enrollment open • Colon Cancer • Colorectal Cancer • Gastric Cancer • Lung Cancer • Mesothelioma • Oncology • Ovarian Cancer • Pancreatic Cancer • Solid Tumor • Thymus Cancer
1 to 1
Of
1
Go to page
1